Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $77.93 | $17.37 | 348.69% | 324.71x | 22.69x | 23.81x | 63.83x | 1.60x | $41.15M | 0.60% | $108.58M | 1.23 | $6.89B | 128.59 | ||
| CORT | CORCEPT THERAPEUTICS INC | $91.88 | $23.75 | 286.91% | 199.74x | 153.98x | 12.48x | 15.46x | 1.42x | $119.79M | 1.25% | $637.99M | 6.11 | $9.76B | -1,422.13 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.34 | $2.78 | 200.38% | 119.14x | 73.22x | 4.52x | 110.66x | 1.14x | $47.52M | 3.35% | $13.01M | 0.08 | $1.59B | 29.70 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $298.76 | $91.67 | 225.92% | 68.52x | 39.89x | 9.26x | 37.09x | 1.43x | $641.34M | 1.62% | $1.08B | 8.09 | $41.15B | 44.51 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $63.44 | $17.02 | 272.80% | 64.73x | 49.69x | 6.44x | 8.06x | 1.75x | $164.23M | 3.38% | $605.69M | 7.92 | $4.70B | 42.16 | ||
| KRYS | KRYSTAL BIOTECH INC | $365.81 | $93.70 | 290.40% | 47.20x | 46.73x | 25.67x | 8.45x | 2.25x | $237.38M | 2.22% | $1.28B | 43.59 | $10.29B | 48.10 | ||
| RPRX | ROYALTY PHARMA PLC | $56.43 | $39.18 | 44.02% | 29.54x | 10.58x | 10.10x | 3.27x | 0.64x | $2.34B | 9.50% | $9.94B | 22.75 | $40.86B | 35.12 | ||
| HALO | HALOZYME THERAPEUTICS INC | $76.20 | $70.07 | 8.74% | 25.74x | 9.18x | 5.97x | 41.15x | 0.46x | $667.65M | 7.42% | $219.64M | 1.86 | $10.87B | 17.43 | ||
| VCEL | VERICEL CORP | $47.00 | $8.98 | 423.63% | 109.30x | 97.49x | 8.17x | 6.74x | 2.30x | $47.49M | 1.99% | $356.23M | 7.02 | $2.39B | 59.02 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.12 | $39.65 | 49.12% | 42.23x | 16.00x | 3.51x | 1.84x | 0.60x | $767.06M | 6.74% | $6.21B | 32.27 | $9.78B | 20.28 | ||
| ADMA | ADMA BIOLOGICS INC | $9.08 | $9.04 | 0.44% | 13.16x | 10.82x | 4.20x | 5.39x | 0.55x | $107.90M | 5.03% | $390.33M | 1.65 | $2.16B | 9.77 | ||
| ASND | ASCENDIS PHARMA A | $270.45 | $79.44 | 240.43% | 28.66x | 18.42x | 16.49x | 29.26x | 2.92x | $52.94M | 0.32% | $574.09M | 9.24 | $17.18B | 184.22 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $243.82 | $48.29 | 404.94% | 518.77x | 9.43x | 3.40x | 3.38x | 1.76x | $1.30B | 8.60% | $4.53B | 73.22 | $18.86B | 27.93 | ||
| TGTX | TG THERAPEUTICS INC | $57.12 | $20.47 | 179.03% | 17.74x | 41.10x | 11.78x | 15.00x | 4.96x | -$14.19M | -0.17% | $583.13M | 4.04 | $9.05B | 60.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $316.24 | $92.72 | 241.08% | 40.03x | 34.84x | 22.91x | 6.35x | 2.01x | $122.22M | 1.94% | $997.32M | 50.16 | $6.67B | 29.59 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.84 | $35.18 | 4.70% | 14.56x | 10.09x | 2.37x | 2.34x | 0.55x | $341.79M | 16.05% | $910.35M | 15.75 | $1.70B | 7.18 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.10 | $8.82 | -76.19% | 7.78x | -7.10x | 1.97x | 2.30x | 0.09x | $7.24M | 6.00% | $52.93M | 0.92 | $67.94M | 4.38 | ||
| TECH | BIO-TECHNE CORP | $71.30 | $16.46 | 333.29% | 100.42x | 34.17x | 9.21x | 5.35x | 1.84x | $269.60M | 2.42% | $2.09B | 13.34 | $11.24B | 43.92 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $485.39 | $164.98 | 194.21% | 28.54x | 24.83x | 10.09x | 6.36x | 2.08x | $3.71B | 3.01% | $19.36B | 76.20 | $119.69B | 22.19 | ||
| EXEL | EXELIXIS INC | $56.50 | $30.55 | 84.97% | 18.11x | 17.37x | 6.14x | 7.34x | 1.30x | $917.69M | 6.29% | $1.94B | 7.49 | $14.14B | 13.39 | ||
| UTHR | UNITED THERAPEUTICS CORP | $547.06 | $237.53 | 130.32% | 18.68x | 19.70x | 7.51x | 3.94x | 2.10x | $1.02B | 4.27% | $5.90B | 135.66 | $21.94B | 12.80 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.39 | $2.42 | 40.30% | 14.13x | 14.33x | 2.08x | 3.28x | 0.95x | $4.11M | 1.50% | $82.33M | 1.03 | $206.02M | 9.70 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.47 | $12.56 | 150.51% | 17.39x | 15.80x | 6.44x | 3.80x | 3.25x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.25 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $664.52 | $428.17 | 55.20% | 15.61x | 14.12x | 4.63x | 2.22x | 1.06x | $4.11B | 5.95% | $31.42B | 302.15 | $69.41B | 12.08 | ||
| VCYT | VERACYTE INC | $56.97 | $7.48 | 661.51% | 51.32x | 51.38x | 8.36x | 3.38x | 10.84x | $155.34M | 3.43% | $1.34B | 16.90 | $4.32B | 37.55 | ||
| INCY | INCYTE CORP | $116.71 | $63.78 | 82.99% | 16.01x | 14.75x | 4.34x | 4.15x | 1.48x | $1.45B | 6.24% | $5.62B | 28.21 | $19.89B | 10.63 | ||
| MDXG | MIMEDX GROUP INC | $4.11 | $1.22 | 237.24% | 19.57x | -48.81x | 1.57x | 2.52x | 10.31x | $69.36M | 11.36% | $242.94M | 1.64 | $469.99M | 8.63 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $18.95 | $3.19 | 493.15% | 31.58x | 5.17x | 0.91x | 1.33x | 70.37x | $109.24M | 5.49% | $1.51B | 14.34 | $2.57B | 31.10 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.